{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T11:50:00Z","timestamp":1778068200875,"version":"3.51.4"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To report a case of conjunctival pyogenic granuloma after intravitreal injection of anti\u2013vascular endothelial growth factor, bevacizumab.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A 52-year-old patient after 3 intravitreal bevacizumab injections was found to have a vascular conjunctival nodule at the injection site. A pathologic analysis of the vascular conjunctival nodule was performed after surgical excision.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The pathologic analysis revealed a conjunctival pyogenic granuloma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Conjunctival pyogenic granuloma can complicate an otherwise uneventful intravitreal anti\u2013vascular endothelial growth factor injection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/icb.0b013e31828ef010","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T09:30:41Z","timestamp":1364981441000},"page":"291-293","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["CONJUNCTIVAL PYOGENIC GRANULOMA ASSOCIATED WITH INTRAVITREAL BEVACIZUMAB INJECTION"],"prefix":"10.1097","volume":"7","author":[{"given":"Oded","family":"Sagiv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilia","family":"Piven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mordechai","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-28-20240721","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Group, Martin DF, Maguire MG, et al.. Ranibizumab and bevacizumab for neovascular age-related macular degeneration.","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"R2-28-20240721","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/bjo.2006.099598","article-title":"The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.","volume":"90","author":"Fung","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R3-28-20240721","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/bjo.2009.178574","article-title":". Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review.","volume":"95","author":"Schmucker","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R4-28-20240721","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1874364101105010059","article-title":". Presumed pyogenic granuloma associated with intravitreal anti-vascular endothelial growth factor therapy.","volume":"5","author":"Jung","year":"2011","journal-title":"Open Ophthalmol J"},{"key":"R5-28-20240721","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.ophtha.2011.04.034","article-title":". Vascular tumors of the conjunctiva in 140 cases.","volume":"118","author":"Shields","year":"2011","journal-title":"Ophthalmology"},{"key":"R6-28-20240721","first-page":"327","article-title":"Pyogenic granulomas of the eye and ocular adnexa: a study of 100 cases.","volume":"87","author":"Ferry","year":"1989","journal-title":"Trans Am Ophthalmol Soc"}],"container-title":["RETINAL Cases &amp; Brief Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01271216-201300730-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T08:01:41Z","timestamp":1721548901000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01271216-201300730-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/icb.0b013e31828ef010","relation":{},"ISSN":["1935-1089"],"issn-type":[{"value":"1935-1089","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}